Rigel Pharmaceuticals, Inc. to Present at Citi’s Biotech Day

SOUTH SAN FRANCISCO, Calif., March 27 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. today announced that James M. Gower, the company’s chairman and chief executive officer, is scheduled to present a company overview at Citi’s 4th Annual Biotech Day in New York City on Wednesday, April 1st at 10:40 a.m. EDT.

To access the live audio webcast or the subsequent archived recording, log on to www.rigel.com. Please connect to Rigel’s website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and metabolic diseases. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel’s productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

CONTACT: Ryan Maynard of Rigel Pharmaceuticals, Inc., +1-650-624-1284,
invrel@rigel.com

Web site: http://www.rigel.com/

MORE ON THIS TOPIC